Recent events
Recent events tied to this brand in public sources.
Back to profile26 entries · Page 1 of 2
2022
Haixin Zhihui completes B1 funding round
Haixin Zhihui announced that it had completed a B1 funding round worth several hundred million yuan. Qiming Venture Partners led the round, with Hepei Investment also participating.
2022
XinXin Technology completes two funding rounds
XinXin Technology completed two consecutive investment rounds, an angel round and an angel-plus round, raising tens of millions of U.S. dollars in total. Lenovo Capital invested in the angel round; Qiming Venture Partners led the angel-plus round, with other investors participating.
2022
Huazhuo Technology completes RMB 100 million A++ funding round
Huazhuo Technology announced completion of an RMB 100 million A++ funding round led by Qiming Venture Partners.
2022
DP Technology completes Series B funding
DP Technology announced that it had completed a Series B funding round worth tens of millions of US dollars, co-led by Source Code Capital and Qiming Venture Partners, with existing investors including Hillhouse Capital and Matrix Partners also participating.
2022
Qiming Venture Partners and China Foundation for Poverty Alleviation launch rural entrepreneur support program
Qiming Venture Partners and China Foundation for Poverty Alleviation launched the China Rural Revitalization Entrepreneur Support Plan. Qiming said it would donate RMB 1 billion to the plan, which is intended to train and empower 2,000 rural entrepreneurs and cultivate 40 social organizations in 40 counties.
2022
Qiming Venture Partners promotes team members
Qiming Venture Partners announced promotions including Bonnie Wang and Dr. Kan Chen to Partner and Xiaofei Zhou to Vice President, along with eight promotions in finance, legal and administrative support teams.
2021
Houmo Intelligence raises RMB 300 million in Pre-A funding
Houmo Intelligence announced that it completed a RMB 300 million Pre-A funding round led by Qiming Venture Partners, with existing and additional investors participating.
2021
Vistel completes nearly RMB 100 million Series B funding
Beijing Vistel Technology announced that it had completed nearly RMB 100 million in Series B funding. Qiming Venture Partners led the round, with existing investor Danlu Capital participating.
2021
Hochuen Medical raises RMB 40 million in Series A financing
Hochuen Medical raised RMB 40 million in a Series A financing round led by Qiming Venture Partners as the sole investor. The company said proceeds would support market expansion, process and technology development, and production-capacity expansion.
2021
Hechuan Medical completes Series A1 financing
Hechuan Medical completed a financing round of tens of millions of yuan, with Qiming Venture Partners as the sole investor. The proceeds are intended to support expansion of its domestic and international CDMO business, technology and production-process development, and capacity expansion.
2021
Yunzhisheng completes nearly US$100 million D+ funding round
Yunzhisheng received nearly US$100 million in D+ round financing on June 24. The article says the funding would be used for technology research and development, product improvement, and expanding commercial channels.
2021
Xiaoe-Tech completes US$120 million Series D funding
Xiaoe-Tech announced that it had completed a US$120 million Series D funding round, led by IDG Capital with participation from Qiming Venture Partners, GGV Capital, and Hillhouse Capital.
2021
IntoCare completes Series D funding
IntoCare announced that it had completed a Series D funding round worth hundreds of millions of yuan, led by Qiming Venture Partners, with investment from Oriza Holdings, Oriza Seed and Yuanbio Venture Capital.
2021
Shengzhe Medical completes RMB 100 million Series A financing
Shengzhe Medical completed a RMB 100 million Series A financing led by Qiming Venture Partners, with Taifu Capital and existing shareholders also participating. The company said it planned to use the funds to accelerate its energy-based surgical products and market expansion.
2021
Moleyuan completes Series B funding
Moleyuan announced that it completed a Series B funding round worth hundreds of millions of yuan, with Qiming Venture Partners as the sole investor.
2021
MediLink Therapeutics closes $50 million Series A financing
MediLink Therapeutics announced that it had closed a $50 million Series A financing, with a Series-A1 round led by Apricot Capital and a Series-A2 round co-led by Loyal Valley Capital and Qiming Venture Partners.
2021
Yunji Technology completes Series C funding
Service robotics company Yunji Technology announced that it had completed a Series C funding round led by Qiming Venture Partners, with CITIC Securities Investment participating and existing shareholders Tencent, Lenovo Capital, Boiling Point Capital and Lanting Capital continuing to invest.
2021
Kira Pharmaceuticals announces $53.5 million B+ financing
Kira Pharmaceuticals announced a $53.5 million first closing of its B+ financing, with funding provided by RA Capital, Vivo Capital, Foresite Capital, APlus Partners and existing investors Quan Capital and Qiming Venture Partners.
2020
Fushoukang secures Series B funding
Fushoukang announced that it had secured tens of millions of US dollars in Series B funding, led by Qiming Venture Partners, with Tonglong Capital and existing investor CDH Investments also participating. The funding is intended to support expansion of its home-care services from Shanghai across China, continued investment in its information platform, and rollout of customized services.
2020
Yuanxin Technology completes 600 million yuan D1 funding round
Yuanxin Technology announced that it had completed a D1 funding round of 600 million yuan, with investment from Sequoia China, Qiming Venture Partners, Yingke Capital, CITIC Securities and Index Capital.